Press Releases

See our press releases below:

03/23/2010: Acceleron and Collaborators Publish Two Papers on ACE-041, a Novel Angiogenesis Inhibitor

03/10/2010: Acceleron Recognized by The Wall Street Journal as One of the Top 50 Venture-Backed Companies in the United States

03/01/2010: Acceleron to Present at the Cowen and Company 30th Annual Health Care Conference

01/14/2010: Acceleron Pharma Announces Addition of Two Novel Programs to Development Pipeline at the 28th Annual JP Morgan Healthcare Conference

01/07/2010: Acceleron Pharma to Present at the 28th Annual J.P. Morgan Healthcare Conference

12/22/2009: Acceleron Pharma Expands Management Team with Two New Appointments

12/08/2009: Acceleron Pharma Presents Findings of ACE-536, a Novel Red Blood Cell-Forming Agent, at the 51st Annual Meeting of the American Society of Hematology

12/03/2009: Alkermes Licenses Technology Platform for Long-Acting Fusion Proteins from Acceleron Pharma

12/01/2009: Acceleron Pharma to Present Data on ACE-011 and ACE-536 at the 51st Annual Meeting of the American Society of Hematology

11/04/2009: Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer

09/15/2009: Acceleron to Present at the UBS Global Life Sciences Conference

09/10/2009: Acceleron Pharma